EMA Authorised: Kauliv (teriparatide) — Strides Pharma (Cyprus) Limited

View source ↗

Summary

Kauliv (teriparatide) has been authorised by the EMA for osteoporosis-related indications, including postmenopausal osteoporosis, by Strides Pharma (Cyprus) Lim…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Osteoporosis Postmenopausal

Drugs mentioned

• Kauliv (teriparatide)

Snippet

Status: Authorised. Therapeutic area: Osteoporosis;Osteoporosis, Postmenopausal. MAH: Strides Pharma (Cyprus) Limited. Decision date: 26/08/2026